Physician profile
Alan P Boehm
NPI 1851303366
$8,249.40
in general payments reported to CMS, 2019-2025
44 companies · $1,457 in 2025
The $1,457 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $927 · 2021: $481 · 2022: $763 · 2023: $2,148 · 2024: $1,041 · 2025: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,646.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,029.87 | 2023-2025 | |
| Epsfl, LLC | $934.50 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $532.11 | 2019-2022 | |
| Henry Schein, INC. | $500.00 | 2019 | |
| Horizon Therapeutics Plc | $379.68 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $351.39 | 2020-2024 | Jublia |
| Smith+Nephew, INC. | $333.79 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Paratek Pharmaceuticals, INC. | $292.67 | 2021-2024 | Nuzyra |
| Organogenesis INC. | $272.60 | 2022-2025 | Via Matrix, Apligraf |
| Medline Industries LP | $225.13 | 2019 | |
| Bioventus LLC | $222.34 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit |
| Cardiovascular Systems INC. | $203.73 | 2020-2022 | |
| Lifenet Health | $196.45 | 2024-2025 | Theragenesis Wound Matrix |
| Sebela Pharmaceuticals INC. | $187.11 | 2019-2023 | Naftin |
| Ibsa Pharma INC. | $181.33 | 2024-2025 | Tirosint, Licart, Flector |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $173.77 | 2024-2025 | Krystexxa |
| Stryker Corporation | $163.52 | 2023 | Augment Injectable, Citrefix, Easyfuse |
| Next Science LLC | $160.95 | 2023 | Blastx, Xperience, Surgx |
| Globus Medical, INC. | $154.76 | 2025 | Senza |
| Forma Medical | $142.50 | 2024 | Optimalakin |
| Kerecis Limited | $137.39 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Linvatec Corporation | $136.69 | 2025 | Rts Flexible 1st Mpj Implant Wgrommets, Neospan, Biobrace 23mm |
| Abbott Laboratories | $129.43 | 2019-2025 | Proclaim, Eterna |
| Stability Biologics, LLC | $119.91 | 2024 | |
| Grt US Holding, INC. | $118.14 | 2021-2022 | |
| Tactile Systems Technology INC | $110.43 | 2025 | Flexitouch Plus, Nimbl |
| Vertex Pharmaceuticals Incorporated | $100.41 | 2025 | |
| Angiodynamics, INC. | $93.72 | 2022 | |
| Abbvie INC. | $89.08 | 2025 | |
| Averitas Pharma INC. | $81.06 | 2025 | Qutenza |
| Sandoz INC. | $76.00 | 2019-2020 | |
| Arthrosurface Incorporated | $58.90 | 2019 | |
| Medtronic, INC. | $58.55 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Acera Surgical, INC. | $43.02 | 2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $40.27 | 2024-2025 | Motoband |
| Merck Sharp & Dohme LLC | $39.01 | 2019 | |
| Melinta Therapeutics, LLC | $32.85 | 2019 | |
| Glenmark Therapeutics INC. | $29.00 | 2019 | |
| Treace Medical Concepts, INC. | $24.06 | 2025 | |
| Mimedx Group, INC. | $22.66 | 2025 | |
| Acumed LLC | $21.33 | 2024 | Acumed |
| Fidia Pharma USA INC. | $18.35 | 2022 | |
| Integra Lifesciences Corporation | $18.34 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Osiris Therapeutics INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Boehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.